On November 29th, Imperial inaugurated the International Phenome Centre Network (IPCN), at the WISH conference in Doha. Building on the best-practices established at the MRC-NIHR National Phenome Centre, the IPCN will promote global harmonisation in the field of metabolic phenotyping, and using the data sets generated, conduct research to inform global public health policies and the development of new therapies.
Dame Sally Davies, the UK’s Chief Medical Officer stated:
Phenomic research really is one of the next medical frontiers which can advance our understanding of a whole raft of diseases and conditions. The way we treat autism, cancers, mental health, stroke, obesity, metabolic diseases and type 2 diabetes could all be revolutionised by research in this area. It is also really good for work to cross international boundaries to find ways of tackling the biggest global public health challenges facing us today faster.
For more information see the website at http://phenomenetwork.org